Whole-body diffusion-weighted imaging: the added value to whole-body MRI at initial diagnosis of lymphoma.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  AJR. American journal of roentgenology

• Publication date

  2011-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2214/AJR.10.5692PMID 21862763
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diffusion-weighted MRI of lymphoma: prognostic utility and implications for PET/MRI?

  2013cited by this paper
• PET scan integration in lymphoma management

  2013cited by this paper
• Symmetric multifocal bone marrow involvement diagnosed by whole-body magnetic resonance imaging in a patient with B lymphoblastic lymphoma

  2012cited by this paper
• Advances in oncologic imaging

  2012cited by this paper
• PET/MR for therapy response evaluation in malignant lymphoma: initial experience

  2012cited by this paper
• The diagnostic value of FDG–PET cannot be judged by iliac bone marrow biopsy: Author response

  2012cited by this paper
• Quantitative Assessment of Diffusion-Weighted MR Imaging in Patients with Primary Rectal Cancer: Correlation with FDG-PET/CT

  2010cited by this paper
• Metabolic Activity Measured by F-18 FDG PET in Natural Killer-Cell Lymphoma Compared to Aggressive B- and T-Cell Lymphomas

  2010cited by this paper
• Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma

  2010influential reference
• 18F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients

  2010cited by this paper
• Whole-body PET/CT scanning: estimation of radiation dose and cancer risk.

  2009cited by this paper
• Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging.

  2009cited by this paper
• CT and 18F-FDG PET for noninvasive detection of splenic involvement in patients with malignant lymphoma.

  2009cited by this paper
• Whole-Body MRI, Including Diffusion-Weighted Imaging, for the Initial Staging of Malignant Lymphoma: Comparison to Computed Tomography

  2009cited by this paper
• Role of diffusion-weighted magnetic resonance imaging for predicting of tumor invasiveness for clinical stage IA non-small cell lung cancer.

  2009cited by this paper
• Evaluation of optimized inversion‐recovery fat‐suppression techniques for T2‐weighted abdominal MR imaging

  2008cited by this paper
• Diffusion‐weighted magnetic resonance imaging allows monitoring of anticancer treatment effects in patients with soft‐tissue sarcomas

  2008cited by this paper
• Magnetic resonance imaging for the detection of bone marrow involvement in malignant lymphoma

  2008cited by this paper
• Imaging in staging of malignant lymphoma: a systematic review.

  2008cited by this paper
• Comparison and reproducibility of ADC measurements in breathhold, respiratory triggered, and free‐breathing diffusion‐weighted MR imaging of the liver

  2008cited by this paper
• [Cost considerations for whole-body MRI and PET/CT as part of oncologic staging].

  2008cited by this paper
• Kostenüberlegungen zur Ganzkörper-MRT und PET-CT im Rahmen des onkologischen Stagings

  2008cited by this paper
• Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma.

  2007cited by this paper
• Cancer Statistics, 2007

  2007cited by this paper
• Diffusion-weighted whole-body MR imaging with background body signal suppression: a feasibility study at 3.0 Tesla

  2007cited by this paper
• Diffusion-weighted MRI in the body: applications and challenges in oncology.

  2007cited by this paper
• Body diffusion-weighted MR imaging using high b-value for malignant tumor screening: usefulness and necessity of referring to T2-weighted images and creating fusion images.

  2007cited by this paper
• Value of PET/CT versus PET and CT performed as separate investigations in patients with Hodgkin’s disease and non-Hodgkin’s lymphoma

  2006cited by this paper
• Diffusion-weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity.

  2006cited by this paper
• Emerging techniques: Whole‐body screening and staging with MRI

  2006cited by this paper
• Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma.

  2005cited by this paper
• Schöder H, Noy A, Gönen M, et al. Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin’s lymphoma. J Clin Oncol. 23: 4643-4651

  2005cited by this paper
• Role of positron emission tomography in lymphoma.

  2005cited by this paper
• A comparison of whole-body MRI and CT for the staging of lymphoma.

  2005cited by this paper
• Whole-body MR imaging: evaluation of patients for metastases.

  2004cited by this paper
• Estimated radiation risks potentially associated with full-body CT screening.

  2004cited by this paper
• Initial experience with FSE STIR whole-body MR imaging for staging lymphoma in children

  2004influential reference
• Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display.

  2004cited by this paper
• Three-dimensional volumetric interpolated breath-hold MR imaging for whole-body tumor staging in less than 15 minutes: a feasibility study.

  2002cited by this paper
• Fat suppression in MR imaging: techniques and pitfalls.

  1999cited by this paper

• Comparing Whole-Body Diffusion-weighted MRI to Conventional Imaging: Staging Pediatric Bone and Soft-Tissue Sarcomas.

  2025cites this paper
• Whole-body DWI-MRI as an alternative to 18-FDG-PET/CT in the evaluation of lymphoma.

  2025cites this paper
• Evaluation of diffusion-weighted imaging datasets for the assessment of disease activity in lymphoma patients.

  2025cites this paper
• Lymphoma classification with multi-parametric texture analysis of DWI and PET imaging in Hodgkin and non-Hodgkin lymphoma: a pilot study.

  2025cites this paper
• The Role of Whole-Body MRI in Patients with Lymphoma: A Narrative Review

  2025cites this paper
• Role of whole body MRI in paraneoplastic/autoimmune syndromes: An MRPET study to standardize protocols, pattern interpretation, and establish yield of MRI

  2024cites this paper
• Imaging of ovarian lymphoma

  2023cites this paper
• Case Report

  2023cites this paper
• Whole-body diffusion-weighted imaging with background body signal suppression and quantitative apparent diffusion coefficient in the detection, staging, and grading of non-Hodgkin lymphoma

  2023cites this paper
• The role of ADC histogram analysis in the diagnosis of pediatric malignant lymphadenopathy

  2023cites this paper
• Joint Deformable Image Registration and ADC Map Regularization: Application to DWI-Based Lymphoma Classification

  2022cites this paper
• Integrated Quad-Scanner Strategy-Based Optical Coherence Tomography for the Whole-Directional Volumetric Imaging of a Sample

  2021cites this paper
• The diagnostic performance of whole-body MRI in the staging of lymphomas in adult patients compared to PET/CT and enhanced reference standard-systematic review and meta-analysis.

  2021cites this paper
• Whole-body diffusion-weighted MRI in lymphoma-comparison of global apparent diffusion coefficient histogram parameters for differentiation of diseased nodes of lymphoma patients from normal lymph nodes of healthy individuals.

  2021cites this paper
• Oncologically Relevant Findings Reporting and Data System (ONCO-RADS): Guidelines for the Acquisition, Interpretation, and Reporting of Whole-Body MRI for Cancer Screening.

  2021cites this paper
• Assessment of naive indolent lymphoma using whole-body diffusion-weighted imaging and T2-weighted MRI: results of a prospective study in 30 patients

  2021cites this paper
• Use of Magnetic Resonance Imaging in the Evaluation of Mediastinal and Systemic Disease in Lymphoma. A Systematic Review

  2020cites this paper
• Whole Body 3.0 T Magnetic Resonance Imaging in Lymphomas: Comparison of Different Sequence Combinations for Staging Hodgkin’s and Diffuse Large B Cell Lymphomas

  2020cites this paper
• Integrated slice-specific dynamic shimming for whole-body diffusion-weighted MR imaging at 1.5 T

  2020cites this paper
• Whole-Body MRI in Pediatric Oncology

  2019cites this paper
• Magnetic Resonance Imaging of the Perirenal Space and Retroperitoneum.

  2019cites this paper
• Whole body MRI with diffusion sequence Versus FDG-PET/CT: Correlation study on children, adolescents and young adults with Hodgkin lymphoma

  2019influential citation
• PET/MR Imaging of the Female Pelvis.

  2019cites this paper
• Comparative Study between 18F FDG-PET/CT and Whole Body MRI DWIBS in Assessment of Recurrent Breast Cancer (Prospective, Comparative, Cross-sectional Study Design)

  2019cites this paper
• An update on Burkitt lymphoma: a review of pathogenesis and multimodality imaging assessment of disease presentation, treatment response, and recurrence

  2019cites this paper
• Diagnostic accuracy of diffusion‐weighted imaging‐ magnetic resonance imaging compared to positron emission tomography/computed tomography in evaluating and assessing pathological response to treatment in adult patients with lymphoma: A systematic review

  2018cites this paper
• The role of F-18 positron emission tomography/computed tomography in evaluation of extranodal lymphoma

  2018cites this paper
• Feasibility of diffusion-weighted imaging with DWIBS in staging Hodgkin lymphoma in pediatric patients: comparison with PET/CT

  2018cites this paper
• Whole-body magnetic resonance imaging (WB-MRI) in oncology: recommendations and key uses

  2018cites this paper
• F-18 FDG PET-CT Versus Contrast Enhanced CT in Detection of Extra Nodal Involvement in Patients with Lymphoma

  2018cites this paper
• Whole-body MRI versus 18F-FDG PET/CT for pretherapeutic assessment and staging of lymphoma: a meta-analysis

  2018cites this paper
• Application of DWIBS in malignant lymphoma: correlation between ADC values and Ki-67 index

  2018cites this paper
• PET/MR Imaging: Current and Emerging Applications

  2018cites this paper
• Whole-body Mri versus 18 F-FDg PeT/cT for pretherapeutic assessment and staging of lymphoma: a meta-analysis

  2018cites this paper
• Can diffusion-weighted whole-body MRI replace contrast-enhanced CT for initial staging of Hodgkin lymphoma in children and adolescents?

  2018cites this paper
• Improving lymph node characterization in staging malignant lymphoma using first‐order ADC texture analysis from whole‐body diffusion‐weighted MRI

  2018cites this paper
• PET/CT in lymphoma staging? On the road to a new gold standard

  2018cites this paper
• Bone Marrow Involvement in Malignant Lymphoma: Evaluation of Quantitative PET and MRI Biomarkers.

  2017cites this paper
• Whole body MRI with qualitative and quantitative analysis of DWI for assessment of bone marrow involvement in lymphoma

  2017cites this paper
• Evaluation of Whole Body DiffusionWeighted Imaging in the Staging and Treatment Response of Lymphoma Compared With Fluoride-Oxyglucose (FDG) PET/CT as a Reference Standard

  2017cites this paper
• How PET/MR Can Add Value for Children with Cancer

  2017cites this paper
• Assessment of chemotherapy response in non-Hodgkin lymphoma involving the neck utilizing diffusion kurtosis imaging: a preliminary study.

  2017cites this paper
• Deformable Group-wise Image Registration for Motion Estimation in 4D Medical Imaging

  2017cites this paper
• Localisations rachidiennes des lymphomes

  2017cites this paper
• Whole-body MRI in children: Would a 3D STIR sequence alone be sufficient for investigating common paediatric conditions? A comparative study.

  2017cites this paper
• Enregistrement d'Image Déformable en Groupe pour l'Estimation de Mouvement en Imagerie Médicale en 4D

  2017cites this paper
• Whole-Body MRI: Current Applications in Oncology.

  2017cites this paper
• Pitfalls in whole body MRI with diffusion weighted imaging performed on patients with lymphoma: What radiologists should know.

  2016cites this paper
• Whole-Body MR Imaging: Musculoskeletal Applications.

  2016cites this paper
• Accuracy of whole-body MRI in the assessment of splenic involvement in lymphoma

  2016cites this paper
• Role of WB-MR/DWIBS compared to 18F-FDG PET/CT in the therapy response assessment of lymphoma

  2016cites this paper
• Application value of diffusion weighted whole body imaging with background body signal suppression in monitoring the response to treatment of bone marrow involvement in lymphoma

  2016cites this paper
• The Promise of Hybrid PET\/MRI: Technical advances and clinical applications

  2016cites this paper
• Chemical shift and diffusion-weighted magnetic resonance imaging of the anterior mediastinum in oncology: Current clinical applications in qualitative and quantitative assessment.

  2016cites this paper
• Evaluation of a Fast Protocol for Staging Lymphoma Patients with Integrated PET/MRI

  2016cites this paper
• Whole-Body MRI Screening in Asymptomatic Subjects; Preliminary Experience and Long-Term Follow-Up Findings

  2016cites this paper
• Optimal Estimation of Diffusion in DW-MRI by High-Order MRF-Based Joint Deformable Registration and Diffusion Modeling

  2016cites this paper
• Whole-Body Diffusion Imaging Applying Simultaneous Multi-Slice Excitation

  2016cites this paper
• Contribution of magnetic resonance imaging in lung cancer imaging.

  2016cites this paper
• Hybrid FDG-PET/MR compared to FDG-PET/CT in adult lymphoma patients

  2016cites this paper
• Imaging of Extranodal Genitourinary Lymphoma.

  2016cites this paper
• PET/MR Imaging in Cancers of the Gastrointestinal Tract.

  2016cites this paper
• Usefulness of diffusion-weighted MR imaging for differentiating between benign and malignant superficial soft tissue tumours and tumour-like lesions.

  2016cites this paper
• Can diffusion-weighed whole-body magnetic resonance imaging with body signal suppression play a role in the management of lymphoma patients?

  2016cites this paper
• Clinical application of PET/MRI in oncology

  2016cites this paper
• Whole-Body Diffusion Imaging Applying Simultaneous Multi-Slice Excitation

  2016cites this paper
• (18)F-Fluorodeoxyglucose PET/MR Imaging in Lymphoma.

  2016cites this paper
• Utility of ADC Measurements in the Discrimination between Benign and Lymphomatous Abdomino-Pelvic Lymph Nodes

  2016cites this paper
• Comparison between whole-body MRI with diffusion-weighted imaging and PET/CT in staging newly diagnosed FDG-avid lymphomas.

  2016cites this paper
• Role of diffusion weighted imaging in diagnosis of post transplant lymphoproliferative disorders: Case reports and review of literature

  2016cites this paper
• Whole-body MRI with diffusion-weighted imaging: a valuable alternative to contrast-enhanced CT for initial staging of aggressive lymphoma.

  2016cites this paper
• Pattern of calcification on CT and FDG-PET of a rare perineural mantle cell lymphoma: a potential of non-histological imaging marker

  2016cites this paper
• Place de l’IRM dans le cancer bronchopulmonaire

  2016cites this paper
• Performance of DWI in the Nodal Characterization and Assessment of Lung Cancer: A Meta-Analysis.

  2016cites this paper
• Comparison With F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging

  2016cites this paper
• The Promise of Hybrid PET\/MRI: Technical advances and clinical applications

  2016cites this paper
• Whole-body diffusion-weighted magnetic resonance imaging versus FDG-PET/CT for initial lymphoma staging: systematic review on diagnostic test accuracy studies

  2015cites this paper
• Radiological Features of Gastrointestinal Lymphoma

  2015cites this paper
• Whole‐body MRI‐DWI for assessment of residual disease after completion of therapy in lymphoma: A prospective multicenter study

  2015cites this paper
• Evaluation of staging and early response to chemotherapy with whole‐body diffusion‐weighted MRI in malignant lymphoma patients: A comparison with FDG‐PET/CT

  2015cites this paper
• Neuropathies associated with lymphoma†.

  2015cites this paper
• WB-MR-DWI in aggressive lymphoma: assessment of therapy response

  2015cites this paper
• Whole-body MRI with T1, STIR and DWI: first non-invasive step to rule out bone marrow involvement in aggressive lymphoma - feasibility study

  2015cites this paper
• Whole-Body MRI and 18F-FDG-PET-CT for Lymphoma Staging: Comparison of Patient Experience

  2015cites this paper
• Beyond Whole-Body Imaging: Advanced Imaging Techniques of PET/MRI

  2015cites this paper
• Diagnostic Accuracy of Diffusion-Weighted Magnetic Resonance Imaging Versus Positron Emission Tomography/Computed Tomography for Early Response Assessment of Liver Metastases to Y90-Radioembolization

  2015cites this paper
• PET/MRI for the body imager: abdominal and pelvic oncologic applications

  2015cites this paper
• Staging of Primary Abdominal Lymphomas: Comparison of Whole-Body MRI with Diffusion-Weighted Imaging and 18F-FDG-PET/CT

  2015cites this paper
• Whole-body diffusion-weighted MRI for staging lymphoma at 3.0T: comparative study with MR imaging at 1.5T.

  2015cites this paper
• Diagnostic and functional imaging of thymic and mediastinal involvement in lymphoproliferative disorders.

  2014cites this paper
• ¹H magnetic resonance spectroscopy: a review of the current literature and its potential utility in veterinary oncology.

  2014cites this paper
• Clinical applications of pediatric positron emission tomography-magnetic resonance imaging.

  2014cites this paper
• Functional Imaging in Lymphoma

  2014cites this paper
• Whole-body MRI for initial staging of paediatric lymphoma: prospective comparison to an FDG-PET/CT-based reference standard

  2014cites this paper
• Diffusion‐weighted MRI for staging and evaluation of response in diffuse large B‐cell lymphoma: a pilot study

  2014cites this paper
• Whole body magnetic resonance with diffusion weighted sequence with body signal suppression compared to (18)F-FDG PET/CT in newly diagnosed lymphoma.

  2014cites this paper
• Potential Pediatric Applications of PET/MR

  2014cites this paper
• Magnetic resonance spectroscopy : A review of the current literature and its potential utility in veterinary oncology

  2014cites this paper
• FDG-PET imaging for Hodgkin lymphoma: current use and future applications.

  2014cites this paper
• Very early indicators of response to systemic therapy in lymphoma patients based on alterations in water diffusivity--a preliminary experience in 20 patients undergoing whole-body diffusion-weighted imaging.

  2014cites this paper